Ore Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ore Pharmaceuticals Inc.

ORXE 0.193

+1.8%

Aug 18 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike McFarland who wrote (33)	8/4/2009 10:01:27 PM
From: Mike McFarland	Read Replies (1) of 50

recent news On July 15, 2009 the Company was notified that Nasdaq approved the Company's application to list its Common Stock on The Nasdaq Capital Market. The Company's securities will be transferred from The Nasdaq Global Market to the Nasdaq Capital Market at the opening of business on August 3, 2009. I get a quote just fine on etrade (I don't like to see the quote, but it is there) On July 23, 2009, Mark D. Gessler notified the Board of Directors of Ore Pharmaceuticals Inc. (the "Company") of his resignation as a director of the Company effective immediately. and these... 08/03/2009 James W. Fordyce Named to Ore Pharmaceuticals Board of Directors 07/17/2009 Benjamin L. Palleiko Named Chief Financial Officer of Ore Pharmaceuticals orepharma.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next